Skip to content

Study on the Incidence of Phlebitis in Patients with Hyperlipidemia after Intravenous Administration of Nicotinic Acid and the Impact of Wet Heat Application

Study on the Incidence of Phlebitis in Patients with Hyperlipidemia after Intravenous Administration of Nicotinic Acid and the Impact of Wet Heat Application

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600123201
Enrollment
Unknown
Registered
2026-04-22
Start date
2022-02-24
Completion date
Unknown
Last updated
2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

phlebitis

Interventions

Intervention group:A medical-grade, temperature-controlled moist heating pad was applied. The surface temperature was maintained at 42°C ± 2°C. The compress was positioned longitudinally along the ven
Control group:An identical-appearing device delivering a neutral compress at ambient room temperature (22–24°C) was applied following the exact same timing and duration procedures as the intervention

Sponsors

Beijing Rehabilitation Hospital Affiliated to Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Age = 18 years old. 2. Diagnosed with hyperlipidemia and the doctor's prescription requires intravenous infusion of niacin for treatment. 3. Capable of understanding and voluntarily signing the informed consent form.

Exclusion criteria

Exclusion criteria: 1. There is skin damage, infection, chronic venous insufficiency or lymphedema at the puncture site. 2. Severe heart (NYHA III-IV grade), lung, liver (Child-Pugh B/C grade), or kidney dysfunction (eGFR < 30). 3. Known allergy to niacin or dressing components. 4. Peripheral thermal sensation disorder (such as severe diabetic peripheral neuropathy). 5. Pregnant or lactating women.

Design outcomes

Primary

MeasureTime frame
Incidence of clinically significant phlebitis within 7 days;

Secondary

MeasureTime frame
timing of phlebitis;10-cm Visual Analogue Scale (VAS) Score;

Countries

China

Contacts

Public ContactWang Mengmeng

Beijing Rehabilitation Hospital Affiliated to Capital Medical University

850865988@qq.com+86 187 8825 2551

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: May 1, 2026